Literature DB >> 21691927

Modern management of rare brain metastases in adults.

Matthias J Krammer1, Andre Tomasino, David B Schul, Sabrina T Astner, Michael P Meier, Christianto B Lumenta.   

Abstract

Brain metastases (BM) represent the main cause of intracranial neoplasms in adults, while being relatively less common in children. Today, better treatment options of the primary malignancy lead to higher remission rates as well as prolonged stable clinical conditions. This may in part explain the increased incidence of BM. Morbidity and mortality rates in patients with malignancies deteriorate significantly in cases of metastatic involvement of the central nervous system. Nowadays, especially modern management using surgical, medical, and radiotherapeutic options for treatment of BM tends to improve survival rates and enhance quality of life. Nonetheless, almost all treatment options are considered as palliative. In this review, we outline current knowledge of the incidence, diagnostic facilities, and therapeutic management of rare BM, with consideration of the basic aspects of the primary malignancy.

Entities:  

Mesh:

Year:  2011        PMID: 21691927     DOI: 10.1007/s11060-011-0613-6

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  123 in total

Review 1.  Long-term survival in a patient with brain metastases preceding the diagnosis of endometrial cancer. Report of two cases and review of the literature.

Authors:  E Petru; S Lax; S Kurschel; F Gücer; B Sutter
Journal:  J Neurosurg       Date:  2001-05       Impact factor: 5.115

Review 2.  Brain metastases.

Authors:  Mark E Shaffrey; Melike Mut; Anthony L Asher; Stuart H Burri; Ali Chahlavi; Susan M Chang; Elana Farace; John B Fiveash; Frederick F Lang; M Beatriz S Lopes; James M Markert; David Schiff; Vitaly Siomin; Stephen B Tatter; Michael A Vogelbaum
Journal:  Curr Probl Surg       Date:  2004-08       Impact factor: 1.909

Review 3.  Epithelial ovarian carcinoma metastatic to the central nervous system: a report on two cases with review of literature.

Authors:  A Sood; L Kumar; R Sood; M S Sandhu
Journal:  Gynecol Oncol       Date:  1996-07       Impact factor: 5.482

4.  Carcinomatous meningitis as a clinical manifestation of pancreatic carcinoma.

Authors:  A F Ferreira Filho; F Cardoso; A Di Leo; A Awada; V D da Silva; R B Tovar; G Schwartsmann
Journal:  Ann Oncol       Date:  2001-12       Impact factor: 32.976

Review 5.  Whole brain radiotherapy for the treatment of multiple brain metastases.

Authors:  M N Tsao; N Lloyd; R Wong; E Chow; E Rakovitch; N Laperriere
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

Review 6.  Leptomeningeal carcinomatosis originating from gastric cancer: report of eight cases and review of the literature.

Authors:  Yulia Lisenko; Ashok J Kumar; James Yao; Jaffer Ajani; Linus Ho
Journal:  Am J Clin Oncol       Date:  2003-04       Impact factor: 2.339

7.  Brain metastases in patients with differentiated thyroid carcinoma.

Authors:  P Hjiyiannakis; S Jefferies; C L Harmer
Journal:  Clin Oncol (R Coll Radiol)       Date:  1996       Impact factor: 4.126

Review 8.  Pancreatic carcinoma with brain metastases: case report and literature review.

Authors:  F G El Kamar; K Jindal; M L Grossbard; H H Mizrachi; P S Kozuch
Journal:  Dig Liver Dis       Date:  2004-05       Impact factor: 4.088

Review 9.  PET/CT of esophageal cancer: its role in clinical management.

Authors:  John F Bruzzi; Reginald F Munden; Mylene T Truong; Edith M Marom; Bradley S Sabloff; Gregory W Gladish; Revathy B Iyer; Tin-Su Pan; Homer A Macapinlac; Jeremy J Erasmus
Journal:  Radiographics       Date:  2007 Nov-Dec       Impact factor: 5.333

10.  Evaluation of prognostic factors and treatment modalities in ovarian cancer patients with brain metastases.

Authors:  Noel Anupol; Sharad Ghamande; Kunle Odunsi; Deborah Driscoll; Shashikant Lele
Journal:  Gynecol Oncol       Date:  2002-06       Impact factor: 5.482

View more
  1 in total

1.  Insidious enemy: downside to prolonged survival in prostate cancer.

Authors:  Vaishali Lodhia; Thevamalar Puspanathan
Journal:  BMJ Case Rep       Date:  2017-08-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.